Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Bayer Informs Customers of Important Information About Alcohol Prep Pads in Betaseron Kits
Bayer HealthCare Pharmaceuticals has become aware of the U.S. market recall of alcohol prep pads, alcohol swabs, and alcohol swabsticks manufactured by Triad and marketed under various brand names. The recall of the Triad Group alcohol prep products is due to potential contamination of these products with bacteria that could lead to life-threatening infections. The Triad Group alcohol prep pads are co-packaged and distributed for use with Betaseron in the U.S. Patients should not use these Triad alcohol prep pads due to the recall. There is no involvement or potential contamination of the Betaseron vial or other components in the Betaseron U.S. packaging. This issue is limited to the actual Triad alcohol prep products. For more information, please visit: http://www.fda.gov/Safety/Recalls/ucm240558.htm Further information about the Triad Group recall can be found on the FDA website at http://www.mediguard.org/r/00UzC1AXCgs2
Learn More

McNeil Consumer Healthcare Initiates Voluntary Recall Of Certain Lots of Rolaids Multi-Symptom
Following on from previous recall alerts, McNeil Consumer Healthcare, a Division of McNEIL-PPC, Inc. is voluntarily recalling certain lots of Rolaids Multi-Symptom Berry Tablets in consultation with the Food and Drug Administration (FDA). These products were manufactured at the McNeil plant in Fort Washington, PA prior to April 2010, when production at the facility was suspended. The company is initiating the recall in order to update the labeling. It is very unlikely that the labeling issues impacted the quality of these products. This recall is not being issued because of adverse events. For more information, please visit: http://www.mcneilproductrecall.com/page.jhtml?id=/include/news_jan_2011.inc
Learn More

Date Published Title Drug Source
2011-01-21 Bayer Informs Customers of Important Information About Alcohol Prep Pads in Betaseron Kits Interferon Beta-1B FDA
2011-01-18 McNeil Consumer Healthcare Initiates Voluntary Recall Of Certain Lots of Rolaids Multi-Symptom Rolaids Multi-Symptom Manufacturer
2011-01-18 McNeil Consumer Healthcare Initiates Voluntary Recall of Certain Over-The-Counter (OTC) Products Acetaminophen with Pseudoephedrine Manufacturer
2011-01-18 Genentech Informs Customers of Important Information About Alcohol Prep Pads in Injectable Medicine Kits Ibandronate Sodium FDA
2011-01-16 The FDA Issues Drug Safety Communication: Update to Ongoing Safety Review of Lantus (Insulin Glargine) and Possible Risk of Cancer Insulin Glargine FDA
2011-01-16 The FDA Warns About Possible Risk of Severe Liver Injury with Dronedarone (Multaq) Dronedarone FDA
2011-01-15 Bristol-Myers Squibb Recalls Additional Avalide Tablets Hydrochlorothiazide with Irbesartan Manufacturer
2011-01-13 The FDA Takes New Steps Aimed at Cutting Risks of Severe Liver Injury from Acetaminophen Pentazocine Hydrochloride with APAP FDA
2011-01-11 Reports of Accidental Overdose With Morphine Sulfate Oral Solution 100 mg per 5 mL (20 mg/mL) Morphine FDA
2011-01-11 Novo Nordisk, Inc. A Recalls Single Lot of GlucaGen Hypokit Emergency Kit Glucagon FDA
2011-01-10 Sandoz Inc. Recalls Several Lots of Lorazepam Tablets Lorazepam FDA
2011-01-10 Sandoz Inc. Recalls Single Lot of Carvedilol Tablets Carvedilol FDA
2011-01-10 Teva Pharmaceuticals Inc. Recalls Several Lots of ProAir HFA Albuterol FDA
2011-01-06 Teva Recalls Single Lot of Metronidazole 250 mg Tablets Metronidazole Manufacturer
2011-01-03 Recall - Mislabeled Unit Dose Vials Albuterol Sulfate Inhalation Solution 0.083%, 3 mL Albuterol FDA
2010-12-24 Recombinant Human Growth Hormone (Somatropin): FDA Conducting Ongoing Safety Review Somatropin FDA
2010-12-21 Pfizer Recalls More Bottles of Lipitor Over Strange Smell Atorvastatin Manufacturer
2010-12-20 FDA Publishes Drug Safety Communication: Abnormal Heart Rhythms Associated With Use of Anzemet (Dolasetron Mesylate) Dolasetron FDA
2010-12-16 FDA Begins Process To Remove Breast Cancer Indication From Avastin Prescribing Information Label Bevacizumab FDA
2010-12-14 Accidental Ingestion of Benzonatate (Tessalon) By Children Can Result in Serious Adverse Effects Benzonatate FDA